Previous Article | Next Article ![]()
Journal of Virology, October 2000, p. 9562-9570, Vol. 74, No. 20
Departments of
Neurology,5
Medicine,6
Microbiology,1 and
Immunology,7 University of Colorado
Health Sciences Center, and Neurology Service, Denver Veterans
Affairs Medical Center,8 Denver, Colorado
80220, and Departments of Pediatrics2
and Microbiology and Immunology3 and
Elizabeth B. Lamb Center for Pediatric
Research,4 Vanderbilt University School of
Medicine, Nashville, Tennessee 37232
Received 1 May 2000/Accepted 18 July 2000
Serotype-specific differences in the capacity of reovirus strains
to inhibit proliferation of murine L929 cells correlate with the
capacity to induce apoptosis. The prototype serotype 3 reovirus strains
Abney (T3A) and Dearing (T3D) inhibit cellular proliferation and induce
apoptosis to a greater extent than the prototype serotype 1 reovirus
strain Lang (T1L). We now show that reovirus-induced inhibition of
cellular proliferation results from a G2/M cell cycle
arrest. Using T1L × T3D reassortant viruses, we found that
strain-specific differences in the capacity to induce G2/M
arrest, like the differences in the capacity to induce apoptosis, are
determined by the viral S1 gene. The S1 gene is bicistronic, encoding
the viral attachment protein
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Reovirus-Induced G2/M Cell Cycle Arrest
Requires
1s and Occurs in the Absence of Apoptosis
1 and the nonstructural protein
1s.
A
1s-deficient reovirus strain, T3C84-MA, fails to induce
G2/M arrest, yet retains the capacity to induce apoptosis, indicating that
1s is required for reovirus-induced G2/M
arrest. Expression of
1s in C127 cells increases the percentage of
cells in the G2/M phase of the cell cycle, supporting a
role for this protein in reovirus-induced G2/M arrest.
Inhibition of reovirus-induced apoptosis failed to prevent
virus-induced G2/M arrest, indicating that G2/M
arrest is not the result of apoptosis related DNA damage and suggests
that these two processes occur through distinct pathways.
*
Corresponding author. Mailing address: Department of
Neurology (B-182), University of Colorado Health Sciences Center, 4200 E. 9th Ave., Denver, CO 80262. Phone: (303) 393-2874. Fax: (303) 393-4686. E-mail: Ken.Tyler{at}UCHSC.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|